Nektar Therapeutics Reports First Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 37.77 +0.88 (2.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.89 | 52 Week High | $19.98 | |||
| Open | $37.15 | 52 Week Low | $10.52 | |||
| Day High | $38.74 | P/E | N/A | |||
| Day Low | $36.94 | EPS | $-1.45 | |||
| Volume | 381,738 | |||||
